Brain Tumor Res Treat. 2018 Apr;6(1):31-38. doi: 10.14791/btrt.2018.6.e5.
Mitochondrial 10398A>G NADH-Dehydrogenase Subunit 3 of Complex I Is Frequently Altered in Intra-Axial Brain Tumors in Malaysia.
Brain tumor research and treatment
Abdul Aziz Mohamed Yusoff, Fatin Najwa Zulfakhar, Siti Zulaikha Nashwa Mohd Khair, Wan Salihah Wan Abdullah, Jafri Malin Abdullah, Zamzuri Idris
Affiliations
Affiliations
- Department of Neurosciences, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, Kelantan, Malaysia. [email protected].
- School of Health Sciences, Universiti Sains Malaysia, Health Campus, Kelantan, Malaysia.
- Department of Neurosciences, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, Kelantan, Malaysia.
- Center for Neuroscience Services and Research, Universiti Sains Malaysia, Health Campus, Kelantan, Malaysia.
PMID: 29717568
PMCID: PMC5932297 DOI: 10.14791/btrt.2018.6.e5
Abstract
BACKGROUND: Mitochondria are major cellular sources of reactive oxygen species (ROS) generation which can induce mitochondrial DNA damage and lead to carcinogenesis. The mitochondrial 10398A>G alteration in NADH-dehydrogenase subunit 3 (ND3) can severely impair complex I, a key component of ROS production in the mitochondrial electron transport chain. Alteration in ND3 10398A>G has been reported to be linked with diverse neurodegenerative disorders and cancers. The aim of this study was to find out the association of mitochondrial ND3 10398A>G alteration in brain tumor of Malaysian patients.
METHODS: Brain tumor tissues and corresponding blood specimens were obtained from 45 patients. The ND3 10398A>G alteration at target codon 114 was detected using the PCR-RFLP analysis and later was confirmed by DNA sequencing.
RESULTS: Twenty-six (57.8%) patients showed ND3 10398A>G mutation in their tumor specimens, in which 26.9% of these mutations were heterozygous mutations. ND3 10398A>G mutation was not significantly correlated with age, gender, and histological tumor grade, however was found more frequently in intra-axial than in extra-axial tumors (62.5% vs. 46.2%, p<0.01).
CONCLUSION: For the first time, we have been able to describe the occurrence of ND3 10398A>G mutations in a Malaysian brain tumor population. It can be concluded that mitochondrial ND3 10398A>G alteration is frequently present in brain tumors among Malaysian population and it shows an impact on the intra-axial tumors.
Copyright © 2018 The Korean Brain Tumor Society, The Korean Society for Neuro-Oncology, and The Korean Society for Pediatric Neuro-Oncology.
Keywords: Brain tumor; Malaysia; Mitochondrial DNA; ND3 A10398G mutation
Conflict of interest statement
The authors have no financial conflicts of interest.
References
- Methods Mol Biol. 2009;471:291-303 - PubMed
- Malays J Med Sci. 2012 Jan;19(1):36-42 - PubMed
- Mol Med Rep. 2012 Nov;6(5):923-30 - PubMed
- Biomed Res Int. 2014;2014:540236 - PubMed
- Expert Rev Mol Med. 2002 Apr 11;4(9):1-19 - PubMed
- Asian Pac J Cancer Prev. ;17 (12 ):5195-5201 - PubMed
- Respir Med. 2013 Jun;107(6):911-8 - PubMed
- Genet Mol Res. 2015 Dec 21;14 (4):17426-31 - PubMed
- Oncol Lett. 2017 Nov;14 (5):5179-5188 - PubMed
- Med J Malaysia. 2014 Dec;69(6):261-7 - PubMed
- Exp Biol Med (Maywood). 2016 Jun;241(12 ):1281-95 - PubMed
- Ann Med. 2005;37(3):222-32 - PubMed
- Mitochondrial DNA. 2015 Feb;26(1):56-60 - PubMed
- World J Gastroenterol. 2014 Apr 14;20(14):3950-9 - PubMed
- Cancer Sci. 2014 Jun;105(6):639-45 - PubMed
- J Hum Genet. 2009 Nov;54(11):647-54 - PubMed
- Am J Hum Genet. 2003 Apr;72 (4):804-11 - PubMed
- Cancer Lett. 2007 May 8;249(2):249-55 - PubMed
- Acta Neuropathol. 2007 Aug;114(2):97-109 - PubMed
- Lancet. 2012 May 12;379(9828):1825-34 - PubMed
- Int J Mol Med. 2014 Jan;33(1):77-82 - PubMed
- Cancer Res. 2006 Feb 1;66(3):1880; author reply 1880-1 - PubMed
- Neurosci Lett. 2004 Jul 15;365(1):28-32 - PubMed
- Annu Rev Pathol. 2010;5:297-348 - PubMed
- Annu Rev Biochem. 1992;61:1175-212 - PubMed
- Cancer Res. 2005 Sep 1;65(17):8028-33 - PubMed
- Biomed Res Int. 2013;2013:612369 - PubMed
- Mitochondrion. 2004 Sep;4(5-6):755-62 - PubMed
- Neurogenetics. 1998 Mar;1(3):197-204 - PubMed
- Oncogene. 2000 Apr 13;19(16):2060-6 - PubMed
- Cancer Prev Res (Phila). 2011 May;4(5):638-54 - PubMed
- World J Gastroenterol. 2013 Dec 21;19(47):8880-6 - PubMed
- Lancet Oncol. 2014 Aug;15(9):e395-403 - PubMed
- Genomics. 1993 Jul;17(1):171-84 - PubMed
- Nat Rev Mol Cell Biol. 2012 Dec;13(12):780-8 - PubMed
- Neuro Oncol. 2015 Jun;17(6):776-83 - PubMed
- Breast Cancer Res Treat. 2010 Jun;121(2):511-8 - PubMed
- Cancer Res. 2007 May 15;67(10):4687-94 - PubMed
- Oncogene. 2006 Aug 7;25(34):4663-74 - PubMed
- Genes Chromosomes Cancer. 2011 Oct;50(10):800-11 - PubMed
- Biochim Biophys Acta. 2011 Jun;1807(6):620-5 - PubMed
- Cancer Genet Cytogenet. 2008 Feb;181(1):16-9 - PubMed
Publication Types